CEL
Basic information
Region (hg38): 9:133061981-133071861
Links
Phenotypes
GenCC
Source:
- maturity-onset diabetes of the young type 8 (Strong), mode of inheritance: AD
- maturity-onset diabetes of the young type 8 (Moderate), mode of inheritance: AD
- maturity-onset diabetes of the young (Supportive), mode of inheritance: AD
- maturity-onset diabetes of the young type 8 (Limited), mode of inheritance: Unknown
- maturity-onset diabetes of the young type 8 (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Maturity-onset diabetes of the young, type 8, with exocrine dysfunction | AD | Endocrine; Gastrointestinal | In addition to endocrine manifestations (diabetes mellitus), recognition and specific treatment for exocrine dysfunction may be beneficial | Endocrine; Gastrointestinal | 16369531; 18544793; 17989309; 19760265; 21784842; 21521318 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (163 variants)
- Maturity-onset_diabetes_of_the_young_type_8 (144 variants)
- Inborn_genetic_diseases (99 variants)
- not_specified (45 variants)
- Monogenic_diabetes (7 variants)
- CEL-related_disorder (5 variants)
- Maturity_onset_diabetes_mellitus_in_young (2 variants)
- Transitory_neonatal_diabetes_mellitus (1 variants)
- Type_2_diabetes_mellitus (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CEL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001807.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 68 | 81 | ||||
missense | 173 | 47 | 230 | |||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 14 | 24 | ||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 1 | 9 | 199 | 119 | 13 |
Highest pathogenic variant AF is 0.0000149048
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CEL | protein_coding | protein_coding | ENST00000372080 | 11 | 9884 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000154 | 0.963 | 124740 | 0 | 69 | 124809 | 0.000276 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.112 | 415 | 421 | 0.985 | 0.0000279 | 4819 |
Missense in Polyphen | 136 | 162.42 | 0.83732 | 1883 | ||
Synonymous | -2.22 | 236 | 196 | 1.20 | 0.0000160 | 1617 |
Loss of Function | 1.96 | 13 | 23.2 | 0.561 | 0.00000118 | 259 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000692 | 0.000690 |
Ashkenazi Jewish | 0.000100 | 0.0000993 |
East Asian | 0.000688 | 0.000668 |
Finnish | 0.0000937 | 0.0000928 |
European (Non-Finnish) | 0.000225 | 0.000221 |
Middle Eastern | 0.000688 | 0.000668 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000166 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes fat and vitamin absorption. Acts in concert with pancreatic lipase and colipase for the complete digestion of dietary triglycerides.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Fat digestion and absorption - Homo sapiens (human);Steroid biosynthesis - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);triacylglycerol degradation;Digestion of dietary lipid;Digestion;Digestion and absorption
(Consensus)
Recessive Scores
- pRec
- 0.368
Haploinsufficiency Scores
- pHI
- 0.369
- hipred
- N
- hipred_score
- 0.271
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.148
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cel
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); liver/biliary system phenotype; digestive/alimentary phenotype;
Gene ontology
- Biological process
- lipid metabolic process;cholesterol catabolic process;neuron cell-cell adhesion;fatty acid catabolic process;protein esterification;pancreatic juice secretion;intestinal cholesterol absorption;lipid digestion;intestinal lipid catabolic process;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;postsynaptic membrane assembly;presynaptic membrane assembly
- Cellular component
- extracellular region;extracellular space;cytoplasm;integral component of plasma membrane;cell surface;synapse;extracellular exosome;presynapse
- Molecular function
- catalytic activity;sterol esterase activity;triglyceride lipase activity;protein binding;heparin binding;hydrolase activity;signaling receptor activity;neurexin family protein binding;acylglycerol lipase activity